Skip to main content
. 2016 Jul 8;158:485–495. doi: 10.1007/s10549-016-3889-6

Fig. 3.

Fig. 3

Overall survival. Time from randomization to death due to any cause. a Overall survival for all patients. b Overall survival for patients with triple-negative (ER− and PgR−) disease. c Overall survival for patients with ER+ or PgR+ disease